Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 17045922)

Published in Free Radic Biol Med on August 25, 2006

Authors

Constanze Bergt1, Takanari Nakano, Jochen Ditterich, Charles DeCarli, Jason P Eiserich

Author Affiliations

1: Department of Internal Medicine, University of California, Davis, CA 95616, USA. cbergt@ucdavis.edu

Articles by these authors

(truncated to the top 100)

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52

The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

A role for neural integrators in perceptual decision making. Cereb Cortex (2003) 4.88

Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke (2004) 4.56

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation (2003) 4.36

Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci U S A (2005) 4.07

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol (2003) 3.75

Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke (2010) 3.75

Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73

Vascular cognitive impairment. Lancet Neurol (2003) 3.73

Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA (2009) 3.62

Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke (2004) 3.13

Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke (2008) 2.84

Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol (2006) 2.79

Microstimulation of macaque area LIP affects decision-making in a motion discrimination task. Nat Neurosci (2006) 2.72

Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71

Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69

Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals. Arch Neurol (2005) 2.54

Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol (2006) 2.46

Framingham stroke risk profile and lowered cognitive performance. Stroke (2004) 2.46

Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37

Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol (2009) 2.26

Heritability of lobar brain volumes in twins supports genetic models of cerebral laterality and handedness. Proc Natl Acad Sci U S A (2002) 2.24

Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol (2012) 2.17

Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett (2005) 2.13

Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08

Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol (2009) 2.05

Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke (2007) 1.96

Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke (2004) 1.96

Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A (2006) 1.95

Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol (2010) 1.94

Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage (2007) 1.93

The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann Neurol (2008) 1.92

Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke (2005) 1.91

Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91

Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A (2004) 1.87

White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke (2008) 1.84

Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80

Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79

White matter hyperintensity penumbra. Stroke (2011) 1.78

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci (2002) 1.69

Radial width of the temporal horn: a sensitive measure in Alzheimer disease. AJNR Am J Neuroradiol (2002) 1.66

Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke (2009) 1.66

Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Circulation (2013) 1.61

Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J Biol Chem (2001) 1.61

Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc Natl Acad Sci U S A (2002) 1.59

Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation (2010) 1.57

Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J Neurosci (2004) 1.57

White matter hyperintensities and cognition: testing the reserve hypothesis. Neurobiol Aging (2009) 1.52

Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol (2013) 1.52

Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet (2012) 1.51

Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR. Inf Process Med Imaging (2009) 1.51

Criterion-referenced validity of a neuropsychological test battery: equivalent performance in elderly Hispanics and non-Hispanic Whites. J Int Neuropsychol Soc (2005) 1.50

Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol (2008) 1.50

Perceptual decisions between multiple directions of visual motion. J Neurosci (2008) 1.48

Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke (2009) 1.47

Heterogeneity of cognitive trajectories in diverse older persons. Psychol Aging (2010) 1.44

Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis (2008) 1.40

Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radic Biol Med (2002) 1.40

Computer-based cognitive training for mild cognitive impairment: results from a pilot randomized, controlled trial. Alzheimer Dis Assoc Disord (2009) 1.39

Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia (2005) 1.37

Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation (2006) 1.35

Amylin deposition in the brain: A second amyloid in Alzheimer disease? Ann Neurol (2013) 1.35

Measuring cognitive reserve based on the decomposition of episodic memory variance. Brain (2010) 1.35

Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke (2014) 1.32

Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke (2009) 1.32

Coevolution of white matter hyperintensities and cognition in the elderly. Neurology (2012) 1.28

Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimers Dement (2012) 1.27

Quantitative genetic modeling of regional brain volumes and cognitive performance in older male twins. Biol Psychol (2002) 1.27

Recruitment of a community-based cohort for research on diversity and risk of dementia. Alzheimer Dis Assoc Disord (2010) 1.25

The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. JAMA Neurol (2013) 1.25

Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci (2003) 1.22

The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol (2004) 1.20

Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol (2008) 1.18

Normal and prostate cancer cells display distinct molecular profiles of alpha-tubulin posttranslational modifications. Prostate (2006) 1.17

Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). Atherosclerosis (2011) 1.17

Linking hippocampal structure and function to memory performance in an aging population. Arch Neurol (2009) 1.17

Genome-wide scan for white matter hyperintensity: the Framingham Heart Study. Stroke (2005) 1.16

Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med (2004) 1.16

Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol (2008) 1.16

Vascular and degenerative processes differentially affect regional interhemispheric connections in normal aging, mild cognitive impairment, and Alzheimer disease. Stroke (2010) 1.15

A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am J Geriatr Psychiatry (2003) 1.14

Sepsis and hypotension: enter kynurenine, move over nitric oxide. Crit Care Med (2011) 1.13

Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging (2008) 1.10

Neural dynamics of choice: single-trial analysis of decision-related activity in parietal cortex. J Neurosci (2012) 1.09

Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism. JAMA Neurol (2013) 1.09

TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08

Cytochrome c: a catalyst and target of nitrite-hydrogen peroxide-dependent protein nitration. Arch Biochem Biophys (2004) 1.08

Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study. Stroke (2013) 1.07

Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume. Neurobiol Aging (2011) 1.07

Loss of fornix white matter volume as a predictor of cognitive impairment in cognitively normal elderly individuals. JAMA Neurol (2013) 1.06

Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. Arch Neurol (2010) 1.06

Current concepts of analysis of cerebral white matter hyperintensities on magnetic resonance imaging. Top Magn Reson Imaging (2005) 1.05

The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol (2010) 1.05

Managing and analysing data from a large-scale study on Framingham Offspring relating brain structure to cognitive function. Stat Med (2004) 1.04

Characteristics and effects of inflammation in end-stage renal disease. Semin Dial (2003) 1.03

Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults. J Am Geriatr Soc (2012) 1.01